close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

165.47 +3.39 (+2.09%)
Streaming Delayed Price Updated: 1:58 PM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Provides Update on Strategic Review
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Third-Quarter 2025 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Chief Financial Officer Transition
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Second-Quarter 2025 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Joins Elly’s Team to Drive Rare Disease Gene Therapy Development
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at William Blair and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Bank of America Health Care Conference
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces First-Quarter 2025 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Barclays Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today